Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation

被引:16
作者
Kurita, Ayumi [1 ]
Miyauchi, Yuu [1 ]
Ikushiro, Shin'ichi [2 ]
Mackenzie, Peter I. [3 ,4 ]
Yamada, Hideyuki [1 ]
Ishii, Yuji [1 ]
机构
[1] Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Mol Life Sci, Fukuoka, Japan
[2] Toyama Prefectural Univ, Fac Engn, Dept Biotechnol, Imizu, Toyama, Japan
[3] Flinders Univ S Australia, Flinders Med Ctr, Sch Med, Dept Clin Pharmacol, Bedford Pk, SA, Australia
[4] Flinders Univ S Australia, Flinders Med Ctr, Flinders Ctr Innovat Canc, Dept Clin Pharmacol, Bedford Pk, SA, Australia
关键词
MESSENGER-RNA EXPRESSION; PHASE-II ENZYMES; CATALYZES MORPHINE; HUMAN BILIRUBIN; LIVER; METABOLISM; CLONING; CELLS; CDNA; CYTOCHROME-P450;
D O I
10.1124/jpet.117.240382
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
UDP-Glucuronosyltransferases (UGTs) are classified into three subfamilies in mice: Ugt1a, 2b, and 2a. In the Ugt1a subfamily, Ugt1a1 and 1a6 appear to correspond to human UGT1A1 and 1A6. The mouse is an important animal for its use in investigations, but the substrate specificities of Ugt isoforms belonging to the 2b subfamily in mice remain largely unknown. To address this issue, we characterized the substrate specificity of all isoforms of the Ugt2b subfamily expressed in the mouse liver. The cDNAs of Ugt1a1, Ugt2a3, and all the Ugt2b isoforms expressed in the liver were reverse-transcribed from the total RNA of male FVB-mouse livers and then amplified. A baculovirus-Sf9 cell system for expressing each Ugt was established. Of all the Ugts examined, Ugt2b34, 2b36, and 2b37 exhibited the ability to glucuronidate morphine with Ugt2b36, the most active in this regard. Ugt1a1, but also Ugt2b34, 2b36, and 2b37 to a lesser extent, preferentially catalyzed the glucuronidation of 17 beta-estradiol on the 3-hydroxyl group (E3G). With these isoforms, E3G formation by Ugt1a1 was efficient; however, Ugt2b5 exhibited a preference for the 17 beta-hydroxyl group (E17G). Ugt2b1 and Ugt2a3 formed comparable levels of E3G and E17G. Ugt2b1 and 2b5 were the only isoforms involved in chloramphenicol glucuronidation. As Ugt2b36 is highly expressed in the liver, it is most likely that Ugt2b36 is a major morphine Ugt inmouse liver. Regarding E3G formation, Ugt1a1, like the human homolog, seems to play an important role in the liver.
引用
收藏
页码:199 / 208
页数:10
相关论文
共 32 条
  • [21] In vitro characterization of belinostat glucuronidation: demonstration of both UGT1A1 and UGT2B7 as the main contributing isozymes
    Dong, Dong
    Zhang, Tianpeng
    Lu, Danyi
    Liu, Jie
    Wu, Baojian
    XENOBIOTICA, 2017, 47 (04) : 277 - 283
  • [22] Nuclear UDP-glucuronosyltransferases: Identification of UGT2B7 and UGT1A6 in human liver nuclear membranes
    Radominska-Pandya, A
    Pokrovskaya, ID
    Little, JM
    Jude, AR
    Kurten, RC
    Czernik, PJ
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 399 (01) : 37 - 48
  • [23] The nuclear receptor Shp regulates morphine withdrawal syndrome via modulation of Ugt2b expression in mice
    Chen, Min
    Guo, Lianxia
    Dong, Dong
    Yu, Fangjun
    Zhang, Tianpeng
    Wu, Baojian
    BIOCHEMICAL PHARMACOLOGY, 2019, 161 : 163 - 172
  • [24] Further Characterization of the Metabolism of Desloratadine and Its Cytochrome P450 and UDP-glucuronosyltransferase Inhibition Potential: Identification of Desloratadine as a Relatively Selective UGT2B10 Inhibitor
    Kazmi, Faraz
    Yerino, Phyllis
    Barbara, Joanna E.
    Parkinson, Andrew
    DRUG METABOLISM AND DISPOSITION, 2015, 43 (09) : 1294 - 1302
  • [25] N-glucuronidation catalyzed by UGT1A4 and UGT2B10 in human liver microsomes: Assay optimization and substrate identification
    Lu, Danyi
    Xie, Qian
    Wu, Baojian
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2017, 145 : 692 - 703
  • [26] Glucuronidation of macelignan by human liver microsomes and expressed UGT enzymes: identification of UGT1A1 and 2B7 as the main contributing enzymes
    Liu, Hongming
    Wu, Zhufeng
    Ma, Zhiguo
    Wu, Baojian
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2014, 35 (09) : 513 - 524
  • [27] Characterization of 17-dihydroexemestane glucuronidation: potential role of the UGT2B17 deletion in exemestane pharmacogenetics
    Sun, Dongxiao
    Chen, Gang
    Dellinger, Ryan W.
    Sharma, Arun K.
    Lazarus, Philip
    PHARMACOGENETICS AND GENOMICS, 2010, 20 (10) : 575 - 585
  • [28] The Effects of N-Glycosylation on the Glucuronidation of Zidovudine and Morphine by UGT2B7 Expressed in HEK293 Cells
    Nagaoka, Kenjiro
    Hanioka, Nobumitsu
    Ikushiro, Shinichi
    Yamano, Shigeru
    Narimatsu, Shizuo
    DRUG METABOLISM AND PHARMACOKINETICS, 2012, 27 (04) : 388 - 397
  • [29] Gossypol Exhibits a Strong Influence Towards UDP-Glucuronosyltransferase (UGT) 1A1, 1A9 and 2B7-Mediated Metabolism of Xenobiotics and Endogenous Substances
    Zhang, Yong-Sheng
    Yuan, Jun
    Fang, Zhong-Ze
    Tu, Yan-Yang
    Hu, Cui-Min
    Li, Gan
    Wang, Liang
    Deng, Jian-Ping
    Yao, Jia-Jiu
    Li, Hai-Rong
    MOLECULES, 2012, 17 (05): : 4896 - 4903
  • [30] Prevalence of UDP-glucuronosyltransferase polymorphisms (UGT1A6*2, 1A7*12, 1A8*3, 1A9*3, 2B7*2, and 2B15*2) in a Saudi population
    Alkharfy, Khalid M.
    Jan, Basit L.
    Afzal, Sibtain
    Al-Jenoobi, Fahad I.
    Al-Mohizea, Abdullah M.
    Al-Muhsen, Saleh
    Halwani, Rabih
    Parvez, Mohammad K.
    Al-Dosari, Mohammed S.
    SAUDI PHARMACEUTICAL JOURNAL, 2017, 25 (02) : 224 - 230